Estrogen induces metastatic potential of papillary thyroid cancer cells through estrogen receptor α and β

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Dong, Wenwu ^a   Zhang, Hao ^a   Li, Jing ^a   Guan, Haixia ^a   He, Liang ^a   Wang, Zhihong ^a   Shan, Zhongyan ^a   Teng, Weiping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GELATINASE B; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL STRAIN BCPAP; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS POTENTIAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID PAPILLARY CARCINOMA; WESTERN BLOTTING;

EID: 84886503852     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/941568     Document Type: Article

References (20)

1. Kabat G. C., Kim M. Y., Wactawski-Wende J., Lane D., Wassertheil-Smoller S., Rohan T. E., Menstrual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women. Cancer Causes and Control 2012 23 12 2031 2040
2. Mazzaferri E. L., Jhiang S. M., Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. The American Journal of Medicine 1994 97 5 418 428 2-s2.0-0027943619 10.1016/0002-9343(94)90321-2 (Pubitemid 24345593)
3. Salvesen H., Njolstad P. R., Akslen L. A., Albrektsen G., Soreide O., Varhaug J. E., Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. The European Journal of Surgery 1992 158 11-12 583 589 2-s2.0-0027097967 (Pubitemid 23025711)
4. Rotstein L., The role of lymphadenectomy in the management of papillary carcinoma of the thyroid. Journal of Surgical Oncology 2009 99 4 186 188 2-s2.0-62749117271 10.1002/jso.21234
5. Huang I. C., Chou F. F., Liu R. T., Long-term outcomes of distant metastasis from differentiated thyroid carcinoma. Clinical Endocrinology 2012 76 3 439 447
6. Rahbari R., Zhang L., Kebebew E., Thyroid cancer gender disparity. Future Oncology 2010 6 11 1771 1779 2-s2.0-78650197771 10.2217/fon.10.127
7. Siegel R., Naishadham D., Jemal A., Cancer statistics, 2013. CA: A Cancer Journal for Clinicians 2013 63 1 11 30
8. Rajoria S., Suriano R., Shanmugam A., Wilson Y. L., Schantz S. P., Geliebter J., Tiwari R. K., Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 2010 20 1 33 41 2-s2.0-75149158390 10.1089/thy.2009.0296
9. Kumar A., Klinge C. M., Goldstein R. E., Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors α and β International Journal of Oncology 2010 36 5 1067 1080 2-s2.0-77950431800 10.3892/ijo-00000588
10. Zeng Q., Chen G. G., Vlantis A. C., van Hasselt C. A., Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Proliferation 2007 40 6 921 935 2-s2.0-36249026963 10.1111/j.1365-2184.2007.00471.x (Pubitemid 350135201)
11. Marino M., Galluzzo P., Ascenzi P., Estrogen signaling multiple pathways to impact gene transcription. Current Genomics 2006 7 8 497 508 2-s2.0-33846066888 10.2174/138920206779315737 (Pubitemid 46068961)
12. Leitman D. C., Paruthiyil S., Vivar O. I., Saunier E. F., Herber C. B., Cohen I., Tagliaferri M., Speed T. P., Regulation of specific target genes and biological responses by estrogen receptor subtype agonists. Current Opinion in Pharmacology 2010 10 6 629 636 2-s2.0-78149495213 10.1016/j.coph.2010.09.009
13. Santin A. P., Furlanetto T. W., Role of estrogen in thyroid function and growth regulation. Journal of Thyroid Research 2011 2011 7 875125 10.4061/2011/875125
14. Park S. H., Cheung L. W., Wong A. S., Leung P. C., Estrogen regulates snail and slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor α Molecular Endocrinology 2008 22 9 2085 2098 2-s2.0-50649124650 10.1210/me.2007-0512
15. Hsu H. H., Liu C. J., Shen C. Y., p38 α MAPK mediates 17 β -Estradiol inhibition of MMP-2 and -9 expression and cell migration in human lovo colon cancer cells. Journal of Cellular Physiology 2012 227 11 3648 3660 10.1002/jcp.24072
16. Zheng S., Huang J., Zhou K., Zhang C., Xiang Q., Tan Z., Wang T., Fu X., 17 β -Estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein ezrin. PLoS ONE 2011 6 7 2-s2.0-79960753506 10.1371/journal.pone.0022439 e22439
17. Zhao G., Nie Y., Lv M., He L., Wang T., Hou Y., ER β -mediated Estradiol enhances epithelial mesenchymal transition of lung adenocarcinoma through increasing transcription of midkine. Molecular Endocrinology 2012 26 8 1304 1315
18. Vivacqua A., Bonofiglio D., Albanito L., Madeo A., Rago V., Carpino A., Musti A. M., Picard D., Andò S., Maggiolini M., 17 β -Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Molecular Pharmacology 2006 70 4 1414 1423 2-s2.0-33748923143 10.1124/mol.106.026344 (Pubitemid 44435994)
19. Rajoria S., Suriano R., George A., Shanmugam A., Schantz S. P., Geliebter J., Tiwari R. K., Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in thyroid cancer. PLoS ONE 2011 6 1 2-s2.0-79251537208 10.1371/journal.pone.0015879 e15879
20. Ding J. X., Feng Y. J., Yao L. Q., Yu M., Jin H. Y., Yin L. H., The reinforcement of invasion in epithelial ovarian cancer cells by 17 β -Estradiol is associated with up-regulation of snail. Gynecologic Oncology 2006 103 2 623 630 2-s2.0-33750167087 10.1016/j.ygyno.2006.04.023 (Pubitemid 44602178)